MEP16808A - Substituted benzimidazole compounds and their use for the treatment of cancer - Google Patents
Substituted benzimidazole compounds and their use for the treatment of cancerInfo
- Publication number
- MEP16808A MEP16808A MEP-168/08A MEP16808A MEP16808A ME P16808 A MEP16808 A ME P16808A ME P16808 A MEP16808 A ME P16808A ME P16808 A MEP16808 A ME P16808A
- Authority
- ME
- Montenegro
- Prior art keywords
- cancer
- treatment
- benzimidazole compounds
- substituted benzimidazole
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
- C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Nova jedinjenja benzoimidazola i njihova primjena kao inhibitorna jedinjenja ciklin -zavisnih kinaza kao i novi farmaceutski preparati koji sadrže ova jedinjenja.Novel benzoimidazole compounds and their use as inhibitors of cyclin-dependent kinases as well as new pharmaceutical preparations containing these compounds.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01402460A EP1298125A1 (en) | 2001-09-26 | 2001-09-26 | Substituted benzimidazole compounds and their use for the treatment of cancer |
| YUP-214/04A RS50896B (en) | 2001-09-26 | 2002-09-26 | Substituted benzimidazole compounds and their use for the treatment of cancer |
| PCT/EP2002/011353 WO2003028721A2 (en) | 2001-09-26 | 2002-09-26 | Substituted benzimidazole compounds and their use for the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MEP16808A true MEP16808A (en) | 2010-06-10 |
Family
ID=8182891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-168/08A MEP16808A (en) | 2001-09-26 | 2002-09-26 | Substituted benzimidazole compounds and their use for the treatment of cancer |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US7041668B2 (en) |
| EP (2) | EP1298125A1 (en) |
| JP (1) | JP4510450B2 (en) |
| KR (1) | KR100891439B1 (en) |
| CN (1) | CN100346786C (en) |
| AR (1) | AR037096A1 (en) |
| AT (1) | ATE386517T1 (en) |
| AU (1) | AU2002337151B2 (en) |
| BR (1) | BR0212856A (en) |
| CA (1) | CA2461622C (en) |
| CO (1) | CO5570675A2 (en) |
| CY (1) | CY1107953T1 (en) |
| DE (1) | DE60225159T2 (en) |
| DK (1) | DK1432417T3 (en) |
| EA (1) | EA006802B1 (en) |
| ES (1) | ES2301682T3 (en) |
| GT (1) | GT200200190A (en) |
| HK (1) | HK1068551A1 (en) |
| HR (1) | HRPK20040293B3 (en) |
| HU (1) | HUP0401756A3 (en) |
| IL (1) | IL161059A0 (en) |
| ME (1) | MEP16808A (en) |
| MX (1) | MXPA04002042A (en) |
| MY (1) | MY135339A (en) |
| NO (1) | NO327008B1 (en) |
| NZ (1) | NZ531246A (en) |
| PA (1) | PA8555501A1 (en) |
| PE (1) | PE20030427A1 (en) |
| PL (1) | PL369527A1 (en) |
| PT (1) | PT1432417E (en) |
| RS (1) | RS50896B (en) |
| SI (1) | SI1432417T1 (en) |
| UY (1) | UY27452A1 (en) |
| WO (1) | WO2003028721A2 (en) |
| ZA (1) | ZA200401887B (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070010573A1 (en) | 2003-06-23 | 2007-01-11 | Xianqi Kong | Methods and compositions for treating amyloid-related diseases |
| AU2011250847B2 (en) * | 2003-06-23 | 2013-06-20 | Bhi Limited Partnership | Methods and compositions for treating amyloid-related diseases |
| US20070208166A1 (en) * | 2003-10-24 | 2007-09-06 | Exelixis, Inc. | Tao Kinase Modulators And Method Of Use |
| DE102004010207A1 (en) | 2004-03-02 | 2005-09-15 | Aventis Pharma S.A. | New 4-benzimidazolyl-3(2H)-pyridazinone derivatives are kinase inhibitors, especially useful for treatment of cancer |
| FR2868421B1 (en) * | 2004-04-01 | 2008-08-01 | Aventis Pharma Sa | NOVEL BENZOTHIAZOLES AND THEIR USE AS MEDICAMENTS |
| EP1598348A1 (en) | 2004-05-18 | 2005-11-23 | Aventis Pharma Deutschland GmbH | Novel pyridazinone derivatives as inhibitors of CDK2 |
| US8044100B2 (en) | 2004-12-22 | 2011-10-25 | Bellus Health Inc. | Methods and compositions for treating amyloid-related diseases |
| UA92180C2 (en) * | 2005-09-06 | 2010-10-11 | Смиткляйн Бичам Корпорейшн | Benzimidazole thiophene compounds as plk inhibitors |
| FR2891273B1 (en) * | 2005-09-27 | 2007-11-23 | Aventis Pharma Sa | NOVEL BENZIMIDAZOLE AND BENZOTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE, IN PARTICULAR AS CMET INHIBITORS |
| DK2089417T3 (en) | 2006-10-12 | 2015-03-23 | Bhi Ltd Partnership | Methods, Compounds, Compositions and Vehicles for Delivery of 3-Amion-1-Propanesulfonic Acid |
| PA8792501A1 (en) | 2007-08-09 | 2009-04-23 | Sanofi Aventis | NEW DERIVATIVES OF 6-TRIAZOLOPIRIDACINA-SULFANIL BENZOTIAZOL AND BENCIMIDAZOL, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICATIONS, PHARMACEUTICAL COMPOSITIONS AND NEW MAIN USE AS MET INHIBITORS. |
| ES2620299T3 (en) * | 2007-10-12 | 2017-06-28 | Abbvie Ireland Unlimited Company | Crystalline form 1 of 2 - ((R) -2-methylpyrrolidin-2-yl) -1H-benzimidazol-4-carboxamide |
| FR2922550B1 (en) | 2007-10-19 | 2009-11-27 | Sanofi Aventis | NOVEL 6-ARYL / HETEROALKYLOXY BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, APPLICATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS CMET INHIBITORS |
| FR2941952B1 (en) | 2009-02-06 | 2011-04-01 | Sanofi Aventis | 6- (6-SUBSTITUTED-TRIAZOLOPYRIDAZINE-SULFANYL) DERIVATIVES 5-FLUORO-BENZOTHIAZOLES AND 5-FLUORO-BENZIMIDAZOLES: PREPARATION, APPLICATION AS MEDICAMENTS AND USE AS INHIBITORS OF MET. |
| FR2941950B1 (en) | 2009-02-06 | 2011-04-01 | Sanofi Aventis | 6- (6-O-SUBSTITUTED-TRIAZOLOPYRIDAZINE-SULFANYL) BENZOTHIAZOLES AND BENZIMIDAZOLES DERIVATIVES: PREPARATION, APPLICATION AS MEDICAMENTS AND USE AS INHIBITORS OF MET. |
| FR2941949B1 (en) | 2009-02-06 | 2011-04-01 | Sanofi Aventis | DERIVATIVES OF 6- (6-O-CYCLOALKYL OR 6-NH-CYCLOALKYL-TRIAZOLOPYRIDAZINE-SULFANYL) BENZOTHIAZOLES AND BENZIMIDAZOLES PREPARATION, APPLICATION AS MEDICAMENTS AND USE AS INHIBITORS OF MET. |
| FR2941951B1 (en) | 2009-02-06 | 2011-04-01 | Sanofi Aventis | 6- (6-NH-SUBSTITUTED-TRIAZOLOPYRIDAZINE-SULFANYL) BENZOTHIAZOLES AND BENZIMIDAZOLES DERIVATIVES: PREPARATION, APPLICATION AS MEDICAMENTS AND USE AS INHIBITORS OF MET. |
| WO2011091152A1 (en) * | 2010-01-22 | 2011-07-28 | Pablo Gastaminza | Inhibitors of hepatitis c virus infection |
| IL257486B (en) | 2015-08-25 | 2022-07-01 | Alnylam Pharmaceuticals Inc | Methods and compositions for treating a proprotein convertase subtilisin kexin (pcsk9) gene-associated disorder |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2441201C2 (en) * | 1974-08-28 | 1986-08-07 | Hoechst Ag, 6230 Frankfurt | 2-Carbalkoxyamino-5 (6) -phenyl-sulfonyloxy-benzimidazoles and process for their preparation |
| DE2541752A1 (en) | 1975-09-19 | 1977-03-24 | Hoechst Ag | ANTHELMINTHICALLY ACTIVE 2-CARBALCOXYAMINO-5 (6) -PHENYL-SULFONYLOXY- BENZIMIDAZOLE AND METHOD FOR THEIR PRODUCTION |
| DE3247615A1 (en) * | 1982-12-23 | 1984-07-05 | Hoechst Ag, 6230 Frankfurt | SUBSTITUTED PHENYLSULFONYLOXYBENZIMIDAZOLE CARBAMINATES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT |
| GB9900752D0 (en) * | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| US6693125B2 (en) * | 2001-01-24 | 2004-02-17 | Combinatorx Incorporated | Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders |
-
2001
- 2001-09-26 EP EP01402460A patent/EP1298125A1/en not_active Withdrawn
-
2002
- 2002-09-17 PE PE2002000913A patent/PE20030427A1/en not_active Application Discontinuation
- 2002-09-24 UY UY27452A patent/UY27452A1/en unknown
- 2002-09-25 GT GT200200190A patent/GT200200190A/en unknown
- 2002-09-25 MY MYPI20023586A patent/MY135339A/en unknown
- 2002-09-26 DE DE60225159T patent/DE60225159T2/en not_active Expired - Lifetime
- 2002-09-26 DK DK02772370T patent/DK1432417T3/en active
- 2002-09-26 CA CA002461622A patent/CA2461622C/en not_active Expired - Fee Related
- 2002-09-26 BR BR0212856-0A patent/BR0212856A/en not_active IP Right Cessation
- 2002-09-26 AU AU2002337151A patent/AU2002337151B2/en not_active Ceased
- 2002-09-26 AT AT02772370T patent/ATE386517T1/en active
- 2002-09-26 ME MEP-168/08A patent/MEP16808A/en unknown
- 2002-09-26 EP EP02772370A patent/EP1432417B1/en not_active Expired - Lifetime
- 2002-09-26 PA PA20028555501A patent/PA8555501A1/en unknown
- 2002-09-26 CN CNB028187458A patent/CN100346786C/en not_active Expired - Fee Related
- 2002-09-26 WO PCT/EP2002/011353 patent/WO2003028721A2/en active IP Right Grant
- 2002-09-26 HU HU0401756A patent/HUP0401756A3/en unknown
- 2002-09-26 EA EA200400475A patent/EA006802B1/en not_active IP Right Cessation
- 2002-09-26 SI SI200230686T patent/SI1432417T1/en unknown
- 2002-09-26 KR KR1020047004365A patent/KR100891439B1/en not_active IP Right Cessation
- 2002-09-26 NZ NZ531246A patent/NZ531246A/en not_active IP Right Cessation
- 2002-09-26 MX MXPA04002042A patent/MXPA04002042A/en active IP Right Grant
- 2002-09-26 RS YUP-214/04A patent/RS50896B/en unknown
- 2002-09-26 IL IL16105902A patent/IL161059A0/en unknown
- 2002-09-26 PT PT02772370T patent/PT1432417E/en unknown
- 2002-09-26 AR ARP020103629A patent/AR037096A1/en unknown
- 2002-09-26 JP JP2003532053A patent/JP4510450B2/en not_active Expired - Fee Related
- 2002-09-26 PL PL02369527A patent/PL369527A1/en not_active Application Discontinuation
- 2002-09-26 ES ES02772370T patent/ES2301682T3/en not_active Expired - Lifetime
-
2004
- 2004-03-08 ZA ZA200401887A patent/ZA200401887B/en unknown
- 2004-03-23 NO NO20041214A patent/NO327008B1/en not_active IP Right Cessation
- 2004-03-25 CO CO04028337A patent/CO5570675A2/en not_active Application Discontinuation
- 2004-03-25 US US10/808,889 patent/US7041668B2/en not_active Expired - Fee Related
- 2004-03-25 HR HR20040293A patent/HRPK20040293B3/en not_active IP Right Cessation
-
2005
- 2005-02-07 HK HK05101028A patent/HK1068551A1/en not_active IP Right Cessation
-
2008
- 2008-05-20 CY CY20081100526T patent/CY1107953T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MEP16808A (en) | Substituted benzimidazole compounds and their use for the treatment of cancer | |
| DE60112312D1 (en) | Imidazole Derivatives as RAF Kinase Inhibitors | |
| CY1105477T1 (en) | FARNESYL PROTEIN TRANSFASE INHIBITORS FOR THE THERAPEUTIC MANAGEMENT OF BREAST CANCER | |
| BRPI0207961A8 (en) | USE OF EPOTHYLONE AND CAPECITABIN ANALOGS TO MANUFACTURE DRUG TO TREAT SOLID CANCEROUS TUMORS AND KIT COMPRISING THE SAID COMPOUNDS. | |
| SE0101387D0 (en) | Novel compounds | |
| ME00142B (en) | Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors | |
| BRPI0415525A (en) | imidazole derivatives and their use as pharmaceutical agents | |
| NO20071875L (en) | Bicyclic amides as kinase inhibitors | |
| CY1106766T1 (en) | PYRIDINE DERIVATIVES AS RAF KINASE INHIBITORS | |
| DE50310516D1 (en) | Fredericamycin DERIVATIVES | |
| EE200300475A (en) | Tyrosine kinase inhibitors, pharmaceutical compositions containing them, and said compounds for use in the treatment of diseases | |
| DE60206911D1 (en) | IMIDAZOLE-2-CARBOXYLAMIDE DERIVATIVES AS RAF KINASE INHIBITORS | |
| SE0301700D0 (en) | Novel compounds | |
| BRPI0510177B8 (en) | compound, pharmaceutical composition and use thereof | |
| NO20024005D0 (en) | Pteridine compounds for the treatment of psoriasis | |
| MX2007002269A (en) | Use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain. | |
| MY138059A (en) | Use of ikb-kinase inhibitors in pain therapy | |
| DE602004020070D1 (en) | THIENOPYRIMIDINE DERIVATIVES AS KALIUM CHANNEL INHIBITORS | |
| SE0302546D0 (en) | New compounds | |
| SE0300098D0 (en) | Use of cyclin D1 inhibitors | |
| TR200101693T2 (en) | Treatment of follicular lymphomas using inhibitors of the lysophoxin (LT) expression pathway. | |
| GB0121494D0 (en) | Compounds | |
| DE60213798D1 (en) | Carbolic derivatives as PDEV inhibitors | |
| DE60010934D1 (en) | Medicines suitable for the treatment of proliferative diseases | |
| ATE431348T1 (en) | THIAEPOTHILONE FOR THE TREATMENT OF CANCER DISEASES |